| Stage | HPQ | % of rev | BMRN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $15.7B | 100.00% | $990M | 100.00% | HPQ ×15.84 |
| Gross profit | $2.9B | 18.79% | $787M | 79.51% | BMRN +60.7pp |
| Operating income | $892M | 5.69% | $111M | 11.21% | BMRN +5.5pp |
| Pre-tax income | $798M | 5.09% | $61M | 6.20% | BMRN +1.1pp |
| Net income | $661M | 4.22% | $45M | 4.52% | BMRN +0.3pp |
| Stage | HPQ | BMRN | Gap · A − B |
|---|---|---|---|
| Revenue | $15.7B100.00% | $990M100.00% | HPQ ×15.84 |
| Gross profit | 18.79%$2.9B | 79.51%$787M | BMRN +60.7pp |
| Operating income | 5.69%$892M | 11.21%$111M | BMRN +5.5pp |
| Pre-tax income | 5.09%$798M | 6.20%$61M | BMRN +1.1pp |
| Net income |
| 4.22%$661M |
| 4.52%$45M |
| BMRN +0.3pp |
No shared counterparties.